SG/PUT/AMGEN/200/0.1/21.06.24 | Market Closed - Deutsche Boerse AG 20:36:35 07/06/2024 BST | ||
| 0.001 EUR | 0.00% |
|
| 6 months | -99.58% | ||
| Current year | -99.23% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 07/06/24 | 0.001 | 0.00% |
| 06/06/24 | 0.001 | 0.00% |
| 05/06/24 | 0.001 | 0.00% |
| 04/06/24 | 0.001 | 0.00% |
| 03/06/24 | 0.001 | 0.00% |
Delayed Quote Deutsche Boerse AG
Last update June 07, 2024 at 08:36 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SQ6QDL |
| ISIN | DE000SQ6QDL3 |
| Date issued | 22/12/2022 |
| Strike | 200 $ |
| Maturity | 21/06/2024 (13 Days) |
| Parity | 10 : 1 |
| Emission price | 1.03 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.45 € |
|---|---|
| Lowest since issue | 0.001 € |
| Spread | 0.071 € |
| Spread % | 98.61% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305
USD
Average target price
316.3
USD
Spread / Average Target
+3.69%
- Stock Market
- Warrants
- Warrant